Scientists Achieve Complete Leukemia Cure in Preclinical Study
Researchers from Institut Pasteur and Inserm have developed a triple-drug therapy that reprograms how cancer cells die, activating the immune system to completely eliminate leukemia in preclinical models, offering a promising new approach for treating blood cancers.